SCHEMBL13348588

SCHEMBL13348588

CC(=O)N1CCN(Cc2cnc(-c3cc4ccc(I)c(N(C)S(=O)(=O)c5cccs5)c4[nH]3)s2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
KMT2A Q03164 4/20 0.34
HTT P42858 1/20 0.34
OGA O60502 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
GCK P35557 1/20 0.32
CHEK1 O14757 1/20 0.32
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 2/20 0.31
NPY5R Q15761 1/20 0.31
SLC2A2 P11168 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
LTA4H P09960 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2660204 0.92 ALDH1A1 (0.42) ALDH1A1LMNAHPGDSMN1; SMN2KMT2A
SCHEMBL2660368 0.89 ALDH1A1 (0.44) ALDH1A1LMNAHPGDSMN1; SMN2KMT2A
SCHEMBL2659654 0.83 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2KMT2AOGAL3MBTL1
SCHEMBL2971603 0.83 ALDH1A1 (0.43) ALDH1A1LMNAHPGDSMN1; SMN2KMT2A
SCHEMBL2659475 0.83 ALDH1A1 (0.37) ALDH1A1LMNASMN1; SMN2KMT2AOGA
SCHEMBL2660486 0.82 ALDH1A1 (0.42) ALDH1A1LMNAHPGDSMN1; SMN2KMT2A
SCHEMBL13203318 0.81 HSD17B10 (0.45) ALDH1A1LMNAHPGDSMN1; SMN2KMT2A
SCHEMBL2659787 0.80 ALDH1A1 (0.36) ALDH1A1HPGDSMN1; SMN2OGAL3MBTL1
SCHEMBL2660698 0.80 ALDH1A1 (0.35) ALDH1A1LMNAHPGDSMN1; SMN2KMT2A
SCHEMBL2660658 0.80 ALDH1A1 (0.36) ALDH1A1LMNASMN1; SMN2OGAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137610-A1 Indole compound YASUMA TSUNEO 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137610-A1 Indole compound GCKR, GPR119, SLC5A1 ALDH1A1 376/4885LMNA 4727/4885HPGD 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.